Finance entity
Every one of those 1 sits in a single category, markets. BioHorizons is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.7 across the same-window beat baseline.
Last mentioned: Feb 19, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, markets. BioHorizons is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Source depth averages 2 original sources per story, versus 2.7 across the same-window beat baseline. At 5, the average consequence score sits below the same-window beat average of 5.8. We currently track 1 Finance story that mention Striate+, all published on February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 174 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Striate+. Shared-story counts are live from our verified record — not editorial picks.
Orthocell Limited has secured a $3 million R&D tax incentive refund, elevating its total cash reserves to $49.6 million. This non-dilutive capital injection strengthens the regenerative medicine company's balance sheet as it scales the global commercialization of its nerve and tissue repair products.
Source: finance.yahoo.com · proactiveinvestors.com
Striate+ is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
